hero-image-clinical-3

Publications

One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction
Kaye D., Hasenfuß G., Neuzil P., et al.
Circ Heart Fail. 2016 Dec; 9(12).

Transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicenter, open label, single-arm, phase 1 trial
Hasenfuß G., Hayward C., Burkhoff D. et al.
Lancet 2016; 387: 1298–304.

Clinical Outcome of Transcatheter Treatment of Heart Failure with Preserved or Mildly Reduced Ejection Fraction Using a Novel Implant
Malek F, Neuzil P, Gustafsson F, et al.
International Journal of Cardiology 2015; 187:227–28.

Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial
Hasenfuβ G, Gustafsson F, Kaye D, et al.
J Card Fail 2015; 21(7): 594-600.

Effects of an Interatrial Shunt on Rest and Exercise Hemodynamics: Results of a Computer Simulation in Heart Failure
Kaye D, Shah S, Borlaug B, et al.
Journal of Cardiac Failure. 2014;20(3):212-21.

Transcatheter Treatment of Heart Failure with Preserved or Mildly Reduced Ejection Fraction Using a Novel Interatrial Implant to Lower Left Atrial Pressure
Søndergaard L, Reddy V, Kaye D, et al.
Eur J Heart Failure 2014; 16:796-801.